Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 12, 2008 - Issue 3
Submit an article Journal homepage
82
Views
7
CrossRef citations to date
0
Altmetric
Review

Nuclear factor kappa B and hepatitis viruses

Yong-Song Guan West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China; Sichuan University, State Key Laboratory of Biotherapy, West China Medical School, Gaopeng Street, Keyuan Road 4, Chengdu 610041, Sichuan Province, China +86 28 818 127 87; +86 28 855 383 59; [email protected]
,
Qing He West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China; Sichuan University, State Key Laboratory of Biotherapy, West China Medical School, Gaopeng Street, Keyuan Road 4, Chengdu 610041, Sichuan Province, China +86 28 818 127 87; +86 28 855 383 59; [email protected]
,
Ming-Quan Wang West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China; Sichuan University, State Key Laboratory of Biotherapy, West China Medical School, Gaopeng Street, Keyuan Road 4, Chengdu 610041, Sichuan Province, China +86 28 818 127 87; +86 28 855 383 59; [email protected]
&
Ping Li West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China; Sichuan University, State Key Laboratory of Biotherapy, West China Medical School, Gaopeng Street, Keyuan Road 4, Chengdu 610041, Sichuan Province, China +86 28 818 127 87; +86 28 855 383 59; [email protected]
Pages 265-280 | Published online: 13 Feb 2008

Bibliography

  • Safioleas M, Lygidakis NJ, Manti C. Hepatitis B today. Hepatogastroenterology 2007;54(74):545-8
  • Capocaccia R, Sant M, Berrino F, et al. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol 2007;102(8):1661-70
  • Raza SA, Clifford GM, Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer 2007;96(7):1127-34
  • Walsh K, Alexander GJ. Update on chronic viral hepatitis. Postgrad Med J 2001;77(910):498-505
  • Kools AM. Hepatitis A, B, C, D, and E. Update on testing and treatment. Postgrad Med 1992;91(3):109-14
  • Narbey A. Update on viral hepatitis. Nurs Times 2005;101(20):55-7
  • Kelly D, Skidmore S. Hepatitis C-Z: recent advances. Arch Dis Child 2002;86(5):339-43
  • Dandri M, Volz TK, Lutgehetmann M, Petersen J. Animal models for the study of HBV replication and its variants. J Clin Virol 2005;34(Suppl 1):S54-62
  • Glebe D, Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 2007;13(1):22-38
  • Tan J, Lok AS. Update on viral hepatitis: 2006. Curr Opin Gastroenterol 2007;23(3):263-7
  • Wu GY, Chen HS. Novel approaches towards conquering hepatitis B virus infection. World J Gastroenterol 2007;13(6):830-6
  • Brasier AR. The NF-κB regulatory network. Cardiovasc Toxicol 2006;6(2):111-30
  • Lee TH, Tai DI, Cheng CJ, et al. Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics. J Biomed Sci 2006;13(1):27-39
  • Pikarsky E, Porat RM, Stein I, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431(7007):461-6
  • Hoffmann A, Xia Y, Verma IM. Inflammatory tales of liver cancer. Cancer Cell 2007;11(2):99-101
  • Seki E, Brenner DA. The role of NF-κB in hepatocarcinogenesis: promoter or suppressor? J Hepatol 2007;47(2):307-9
  • Luedde T, Beraza N, Kotsikoris V, et al. Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 2007;11(2):119-32
  • Higashitsuji H, Higashitsuji H, Liu Y, et al. The oncoprotein gankyrin interacts with RelA and suppresses NF-κB activity. Biochem Biophys Res Commun 2007;363(3):879-84
  • Beraza N, Ludde T, Assmus U, et al. Hepatocyte-specific IKKγ/NEMO expression determines the degree of liver injury. Gastroenterology 2007;132(7):2504-17
  • Park SG, Lee T, Kang HY, et al. The influence of the signal dynamics of activated form of IKK on NF-κB and anti-apoptotic gene expressions: a systems biology approach. FEBS Lett 2006;580(3):822-30
  • Hassan M, Selimovic D, Ghozlan H, Abdel-Kader O. Induction of high-molecular-weight (HMW) tumor necrosis factor (TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation. Cell Signal 2007;19(2):301-11
  • Cooper A, Tal G, Lider O, Shaul Y. Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2. J Immunol 2005;175(5):3165-76
  • Huang IC, Chien CY, Huang CR, Lo SJ. Induction of hepatitis D virus large antigen translocation to the cytoplasm by hepatitis B virus surface antigens correlates with endoplasmic reticulum stress and NF-κB activation. J Gen Virol 2006;87(Pt 6):1715-23
  • Luedde T, Trautwein C. Intracellular survival pathways in the liver. Liver Int 2006;26(10):1163-74
  • Escarcega RO, Fuentes-Alexandro S, Garcia-Carrasco M, Gatica A, Zamora A. The transcription factor nuclear factor-kappa B and cancer. Clin Oncol 2007;19(2):154-61
  • Wullaert A, van Loo G, Heyninck K, Beyaert R. Hepatic tumor necrosis factor signaling and nuclear factor-κB: effects on liver homeostasis and beyond. Endocr Rev 2007;28(4):365-86
  • Egan LJ, Toruner M. NF-κB signaling: pros and cons of altering NF-κB as a therapeutic approach. Ann NY Acad Sci 2006;1072:114-22
  • Kucharczak J, Simmons MJ, Fan Y, Gelinas C. To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis. Oncogene 2003;22(56):8961-82
  • Tian B, Brasier AR. Identification of a nuclear factor kappa B-dependent gene network. Recent Prog Horm Res 2003;58:95-130
  • Yun C, Um HR, Jin YH, et al. NF-κB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival. Cancer Lett 2002;184(1):97-104
  • Mann EA, Stanford S, Sherman KE. Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-κB activation. Virus Res 2006;121:51-7
  • Su F, Schneider RJ. Hepatitis B virus HBx protein activates transcription factor NF-κB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol 1996;70(7):4558-66
  • Weill R, Sirma H, Giannini C, et al. Direct association and nuclear import of the hepatitis B virus X protein with the NF-κB inhibitor IκBα. Mol Cell Biol 1999;19(9):6345-54
  • Huang CF, Lin SS, Ho YC, et al. The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol 2006;3(2):97-106
  • Tai DI, Tsai SL, Chen YM, et al. Activation of nuclear factor κB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 2000;31(3):656-64
  • Sato Y, Kato J, Takimoto R, et al. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor α expression via activation of nuclear factor-κB. Gut 2006;55(12):1801-8
  • Waris G, Livolsi A, Imbert V, Peyron JF, Siddiqui A. Hepatitis C virus NS5A and subgenomic replicon activate NF-κB via tyrosine phosphorylation of IκBα and its degradation by calpain protease. J Biol Chem 2003;278(42):40778-87
  • Choi SH, Hwang SB. Modulation of the transforming growth factor-β signal transduction pathway by hepatitis C virus nonstructural 5A protein. J Biol Chem 2006;281(11):7468-78
  • Ikeda K, Marusawa H, Osaki Y, et al. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Ann Intern Med 2007;146(9):649-56
  • Kanda T, Yokosuka O, Kato N, et al. Hepatitis A virus VP3 may activate serum response element associated transcription. Scand J Gastroenterol 2003;38(3):307-13
  • Choi SH, Jeong SH, Hwang SB. Large hepatitis delta antigen modulates transforming growth factor-β signaling cascades: implication of hepatitis delta virus-induced liver fibrosis. Gastroenterology 2007;132(1):343-57. PMID: 17241884
  • Ishinaga H, Jono H, Lim JH, et al. TGF-β induces p65 acetylation to enhance bacteria-induced NF-κB activation. EMBO J 2007;26(4):1150-62
  • Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007;147(1):28-33
  • Waris G, Siddiqui A. Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication. J Virol 2005;79(15):9725-34
  • Waris G, Huh KW, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-κB via oxidative stress. Mol Cell Biol 2001;21(22):7721-30
  • Gong G, Waris G, Tanveer R, et al. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. Proc Natl Acad Sci USA 2001;98(17):9599-604
  • Johnson CL, Owen DM, Gale M. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense. J Biol Chem 2007;282(14):10792-803
  • Hurgin V, Novick D, Werman A, Dinarello CA, Rubinstein M. Antiviral and immunoregulatory activities of IFN-γ depend on constitutively expressed IL-1α. Proc Natl Acad Sci USA 2007;104(12):5044-9
  • Bose S, Kar N, Maitra R, Didonato JA, Banerjee AK. Temporal activation of NF-κB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses. Proc Natl Acad Sci USA 2003;100(19):10890-5
  • Bose S, Banerjee AK. Innate immune response against nonsegmented negative strand RNA viruses. J Interferon Cytokine Res 2003;23(8):401-12
  • Malmgaard L. Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 2004;24(8):439-54
  • Barber GN. Host defense, viruses and apoptosis. Cell Death Differ 2001;8(2):113-26
  • Hiscott J, Grandvaux N, Sharma S, et al. Convergence of the NF-κB and interferon signaling pathways in the regulation of antiviral defense and apoptosis. Ann NY Acad Sci 2003;1010:237-48
  • Maher SG, Romero-Weaver AL, Scarzello AJ, Gamero AM. Interferon: cellular executioner or white knight? Curr Med Chem 2007;14(12):1279-89
  • Takaoka A, Yanai H. Interferon signalling network in innate defence. Cell Microbiol 2006;8(6):907-22
  • Missale G, Cariani E, Ferrari C. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies? Dig Liver Dis 2004;36(11):703-11
  • Sankar S, Chan H, Romanow WJ, Li J, Bates RJ. IKK-i signals through IRF3 and NFκB to mediate the production of inflammatory cytokines. Cell Signal 2006;18(7):982-93
  • Lee JJ, Huang WT, Shao DZ, Liao JF, Lin MT. Blocking NF-κB activation may be an effective strategy in the fever therapy. Jpn J Physiol 2003;53(5):367-75
  • Wullaert A, Heyninck K, Beyaert R. Mechanisms of crosstalk between TNF-induced NF-κB and JNK activation in hepatocytes. Biochem Pharmacol 2006;72(9):1090-101
  • Pasparakis M, Luedde T, Schmidt-Supprian M. Dissection of the NFκB signalling cascade in transgenic and knockout mice. Cell Death Differ 2006;13(5):861-72
  • Luedde T, Beraza N, Trautwein C. Evaluation of the role of nuclear factor-κB signaling in liver injury using genetic animal models. J Gastroenterol Hepatol 2006;21(Suppl 3):S43-6
  • Assenat E, Gerbal-Chaloin S, Maurel P, Vilarem MJ, Pascussi JM. Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer? Eur J Cancer 2006;42(6):785-92
  • Arsura M, Cavin LG. Nuclear factor-κB and liver carcinogenesis. Cancer Lett 2005;229(2):157-69
  • Norton PA, Reis HM, Prince S, et al. Activation of fibronectin gene expression by hepatitis B virus x antigen. J Viral Hepat 2004;11(4):332-41
  • Katzenellenbogen M, Pappo O, Barash H, et al. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice. Cancer Res 2006;66(8):4001-10
  • Miao J, Chen GG, Chun SY, Lai PP. Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression. Cancer Lett 2006;236(1):115-24
  • Zhang JL, Zhao WG, Wu KL, et al. Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease Hepsin. Arch Virol 2005;150(4):721-41
  • Ikeda K, Saitoh S, Suzuki Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 1998;28(6):930-8
  • Shishodia S, Aggarwal BB. Nuclear factor-κB: a friend or a foe in cancer? Biochem Pharmacol 2004;68(6):1071-80
  • Ravi R, Bedi A. NF-κB in cancer – a friend turned foe. Drug Resist Updat 2004;7(1):53-67
  • Aggarwal BB. Nuclear factor-κB: a transcription factor for all seasons. Expert Opin Ther Targets 2007;11(2):109-10
  • Mayo MW, Baldwin AS. The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 2000;1470(2):M55-62
  • Bharti AC, Aggarwal BB. Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol 2002;64(5-6):883-8
  • Wietek C, Oneill LA. Diversity and regulation in the NF-κB system. Trends Biochem Sci 2007;32(7):311-9
  • Nadiminty N, Chun JY, Hu Y, et al. LIGHT, a member of the TNF superfamily, activates Stat3 mediated by NIK pathway. Biochem Biophys Res Commun 2007;359(2):379-84
  • Tergaonkar V, Perkins ND. p53 and NF-κB crosstalk: IKKα tips the balance. Mol Cell 2007;26(2):158-9
  • Cory AH, Cory JG. Understanding interactions between and among apoptosis inducing pathways in tumor cells. In Vivo 2007;21(2):245-9
  • Huang WC, Ju TK, Huang MC, Chen CC. Phosphorylation of CBP by IKKα promotes cell growth by switching the binding preference of CBP from p53 to NF-κB. Mol Cell 2007;26(1):75-87
  • Moss TN, Vo A, McKeehan WL, Liu L. UXT (Ubiquitously Expressed Transcript) causes mitochondrial aggregation. In Vitro Cell Dev Biol Anim 2007;43(3-4):139-46
  • Sun S, Tang Y, Lou X, et al. UXT is a novel and essential cofactor in the NF-κB transcriptional enhanceosome. J Cell Biol 2007;178(2):231-44
  • Goodrich DW. The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene 2006;25(38):5233-43
  • Zhou Z, Flesken-Nikitin A, Corney DC, et al. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res 2006;66(16):7889-98
  • DeLeo AB, Jay G, Appella E, et al. Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci USA 1979;76(5):2420-4
  • Selivanova G. p53: fighting cancer. Curr Cancer Drug Targets 2004;4(5):385-402
  • Dutta J, Fan Y, Gupta N, Fan G, Gelinas C. Current insights into the regulation of programmed cell death by NF-κB. Oncogene 2006;25(51):6800-16
  • Ahmed-Choudhury J, Russell CL, Randhawa S, et al. Differential induction of nuclear factor-κB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation. Mol Biol Cell 2003;14(4):1334-45
  • Indoh T, Yokota S, Okabayashi T, Yokosawa N, Fujii N. Suppression of NF-κB and AP-1 activation in monocytic cells persistently infected with measles virus. Virology 2007;361(2):294-303
  • Dusheiko G, Antonakopoulos N. Current treatment of hepatitis B. Gut 2008;57(1):105-24
  • Stepnik M, Arkusz J. Molecular events associated with dendritic cells activation by contact sensitizers. Int J Occup Med Environ Health 2003;16(3):191-9
  • Lindner I, Cejas PJ, Carlson LM, et al. Signal transduction in DC differentiation: winged messengers and Achilles' heel. Adv Exp Med Biol 2007;590:1-29
  • Perkins ND. Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 2007;8(1):49-62
  • Luo JL, Kamata H, Karin M. IKK/NF-κB signaling: balancing life and death – a new approach to cancer therapy. J Clin Invest 2005;115(10):2625-32
  • Greten FR, Karin M. The IKK/NF-κB activation pathway – a target for prevention and treatment of cancer. Cancer Lett 2004;206(2):193-9
  • Thomas RK, Sos ML, Zander T, et al. Inhibition of nuclear translocation of nuclear factor-κB despite lack of functional IκBα protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies. Clin Cancer Res 2005;11(22):8186-94
  • Shukla S, Gupta S. Suppression of constitutive and tumor necrosis factor α-induced nuclear factor (NF)-κB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-κB-responsive genes. Clin Cancer Res 2004;10(9):3169-78
  • Higashitsuji H, Liu Y, Mayer RJ, et al. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. Cell Cycle 2005;4(10):1335-7
  • Orfila C, Lepert JC, Alric L, et al. Immunohistochemical distribution of activated nuclear factor κB and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats. Histochem Cell Biol 2005;123(6):585-93
  • Novitskiy G, Ravi R, Potter JJ, et al. Effects of acetaldehyde and TNFα on the inhibitory kappa B-α protein and nuclear factor kappa B activation in hepatic stellate cells. Alcohol Alcohol 2005;40(2):96-101
  • Baeuerle PA. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim Biophys Acta 1991;1072(1):63-80
  • Urban MB, Schreck R, Baeuerle PA. NF-κB contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J 1991;10(7):1817-25
  • Schmitz ML, Baeule PA. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J 1991;10(12):3805-17. PMID: 1935902
  • Blank V, Kourilsky P, Israel A. Cytoplasmic retention, DNA binding and processing of the NF-κB p50 precursor are controlled by a small region in its C-terminus. EMBO J 1991;10(13):4159-67
  • Ledebur HC, Parks TP. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-κB site and p65 homodimers. J Biol Chem 1995;270(2):933-43
  • Prusty BK, Hedau S, Singh A, Kar P, Das BC. Selective suppression of NF-κBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality. Mol Med 2007;13(9-10):518-26
  • Pietila TE, Veckman V, Lehtonen A, et al. Multiple NF-κB and IFN regulatory factor family transcription factors regulate CCL19 gene expression in human monocyte-derived dendritic cells. J Immunol 2007;178(1):253-61
  • Hall G, Hasday JD, Rogers TB. Regulating the regulator: NF-κB signaling in heart. J Mol Cell Cardiol 2006;41(4):580-91. PMID: 16949095
  • Vermeulen L, Vanden Berghe W, Haegeman G. Regulation of NF-κB transcriptional activity. Cancer Treat Res 2006;130:89-102
  • Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev 2004;18(18):2195-224
  • Hoffmann A, Natoli G, Ghosh G. Transcriptional regulation via the NF-κB signaling module. Oncogene 2006;25(51):6706-16
  • Place RF, Haspeslagh D, Giardina C. Induced stabilization of IκBα can facilitate its re-synthesis and prevent sequential degradation. J Cell Physiol 2003;195(3):470-8
  • Kiernan R, Bres V, Ng RW, et al. Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65. J Biol Chem 2003;278(4):2758-66
  • Greene WC, Chen LF. Regulation of NF-κB action by reversible acetylation. Novartis Found Symp 2004;259:208-17; discussion 218-25
  • Chen LF, Greene WC. Assessing acetylation of NF-κB. Methods 2005;36(4):368-75
  • Chen LF, Williams SA, Mu Y, et al. NF-κB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol 2005;25(18):7966-75
  • Yoshimura A, Mori H, Ohishi M, Aki D, Hanada T. Negative regulation of cytokine signaling influences inflammation. Curr Opin Immunol 2003;15(6):704-8
  • Sandborn WJ. Transcending conventional therapies: the role of biologic and other novel therapies. Inflamm Bowel Dis 2001;7(Suppl 1):S9-16
  • Lad SP, Li J, da Silva Correia J, et al. Cleavage of p65/RelA of the NF-κB pathway by Chlamydia. Proc Natl Acad Sci USA 2007;104(8):2933-8
  • Yang MD, Deng QG, Chen S, et al. Hepatoprotective mechanisms of Yan-gan-wan. Hepatol Res 2005;32(4):202-12
  • Wallach D, Arumugam TU, Boldin MP, et al. How are the regulators regulated? The search for mechanisms that impose specificity on induction of cell death and NF-κB activation by members of the TNF/NGF receptor family. Arthritis Res 2002;4(Suppl 3):S189-96
  • Bradham CA, Schemmer P, Stachlewitz RF, Thurman RG, Brenner DA. Activation of nuclear factor-κB during orthotopic liver transplantation in rats is protective and does not require Kupffer cells. Liver Transpl Surg 1999;5(4):282-93
  • Suetsugu H, Iimuro Y, Uehara T, et al. Nuclear factor κB inactivation in the rat liver ameliorates short term total warm ischaemia/reperfusion injury. Gut 2005;54(6):835-42
  • Woon ST, Reddy CB, Drummond CJ, et al. A comparison of the ability of DMXAA and xanthenone analogues to activate NF-κB in murine and human cell lines. Oncol Res 2005;15(7-8):351-64
  • Plumlee CR, Lazaro CA, Fausto N, Polyak SJ. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells. Virol J 2005;2:89. Published online 2 December 2005; doi:10.1186/1743-422X-2-89
  • Gish RG. Improving outcomes for patients with chronic hepatitis B. Hepatol Res 2007;37(sl):S67-78
  • Krastev ZA. The “return” of hepatitis B. World J Gastroenterol 2006;12(44):7081-6
  • Lisker-Melman M, Sayuk GS. Defining optimal therapeutic outcomes in chronic hepatitis. Arch Med Res 2007;38(6):652-60
  • Cao S, Zhang X, Edwards JP, Mosser DM. NF-κB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J Biol Chem 2006;281(36):26041-50
  • Catley M. Dissociated steroids. ScientificWorldJournal 2007;7:421-30
  • Guo Q, Zhao L, You Q, et al. Anti-hepatitis B virus activity of wogonin in vitro and in vivo. Antiviral Res 2007;74(1):16-24
  • Gonzalez-Gallego J, Sanchez-Campos S, Tunon MJ. Anti-inflammatory properties of dietary flavonoids. Nutr Hosp 2007;22(3):287-93
  • Tse AK, Wan CK, Zhu GY, et al. Magnolol suppresses NF-κB activation and NF-κB regulated gene expression through inhibition of IκB kinase activation. Mol Immunol 2007;44(10):2647-58
  • Jawan B, Goto S, Pan TL, et al. The protective mechanism of magnolol, a Chinese herb drug, against warm ischemia-reperfusion injury of rat liver. J Surg Res 2003;110(2):378-82
  • Polyak SJ, Morishima C, Shuhart MC, et al. Inhibition of T-cell inflammatory cytokines, hepatocyte NF-κB signaling, and HCV infection by standardized Silymarin. Gastroenterology 2007;132(5):1925-36
  • Gautam SC, Gao X, Dulchavsky S. Immunomodulation by curcumin. Adv Exp Med Biol 2007;595:321-41
  • Prasad AS. Zinc: mechanisms of host defense. J Nutr 2007;137(5):1345-9
  • Yuasa K, Naganuma A, Sato K, et al. Zinc is a negative regulator of hepatitis C virus RNA replication. Liver Int 2006;26(9):1111-8
  • Harder J, Glaser R, Schroder JM. The role and potential therapeutical applications of antimicrobial proteins in infectious and inflammatory diseases. Endocr Metab Immune Disord Drug Targets 2007;7(2):75-82
  • Hayden MS, West AP, Ghosh S. NF-κB and the immune response. Oncogene 2006;25(51):6758-80
  • De Leeuw E, Lu W. Human defensins: turning defense into offense? Infect Disord Drug Targets 2007;7(1):67-70
  • Proud D, Sanders SP, Wiehler S. Human rhinovirus infection induces airway epithelial cell production of human β-defensin 2 both in vitro and in vivo. J Immunol 2004;172(7):4637-45
  • Baltina LA. Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine. Curr Med Chem 2003;10(2):155-71
  • Lee CH, Park SW, Kim YS, et al. Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice. Biol Pharm Bull 2007;30(10):1898-904
  • Kumada H. Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma. Oncology 2002;62(Suppl 1):94-100
  • Veldt BJ, Hansen BE, Ikeda K, et al. Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon. Scand J Gastroenterol 2006;41(9):1087-94
  • Elsharkawy AM, Mann DA. Nuclear factor-κB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 2007;46(2):590-7
  • Stickel F, Schuppan D. Herbal medicine in the treatment of liver diseases. Dig Liver Dis 2007;39(4):293-304
  • Nakanishi C, Toi M. Nuclear factor-κB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 2005;5(4):297-309

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.